Mutations in the Sterile alpha motif domain containing 9 (SAMD9) gene have been described in patients with severe multisystem disorder, MIRAGE syndrome, but also in patients with bone marrow (BM) failure in the absence of other systemic symptoms. The role of hematopoietic stem cell transplantation (HSCT) in the management of the disease is still unclear. Here, we present a patient with a novel mutation in SAMD9 (c.2471 G>A, p.R824Q), manifesting with prominent gastrointestinal tract involvement and immunodeficiency, but without any sign of adrenal insufficiency typical for MIRAGE syndrome. He suffered from severe CMV (cytomegalovirus) infection at 3 months of age, with a delayed development of T lymphocyte functional response against CMV, profound T cell activation, significantly reduced B lymphocyte counts and impaired lymphocyte proliferative response. Cultured T cells displayed slightly lower calcium flux and decreased survival. At the age of 6 months, he developed severe neutropenia requiring G-CSF administration, and despite only mild morphological and immunophenotypical disturbances in the BM, 78% of the BM cells showed monosomy 7 at the age of 18 months. Surprisingly, T cell proliferation after CD3 stimulation and apoptosis of the cells normalized during the follow-up, possibly reflecting the gradual development of monosomy 7. Among other prominent symptoms, he had difficulty swallowing, requiring percutaneous endoscopic gastrostomy (PEG), frequent gastrointestinal infections, and perianal erosions. He suffered from repeated infections and periodic recurring fevers with the elevation of inflammatory markers. At 26 months of age, he underwent HSCT that significantly improved hematological and immunological laboratory parameters. Nevertheless, he continued to suffer from other conditions, and subsequently, he died at day 440 post-transplant due to sepsis. Pathogenicity of this novel SAMD9 mutation was confirmed experimentally. Expression of mutant SAMD9 caused a significant decrease in proliferation and increase in cell death of the transfected cells. Conclusion: We describe a novel SAMD9 mutation in a patient with prominent gastrointestinal and immunological symptoms but without adrenal hypoplasia. Thus, SAMD9 mutations should be considered as cause of enteropathy in pediatric patients. The insufficient therapeutic outcome of transplantation further questions the role of HSCT in the management of patients with SAMD9 mutations and multisystem involvement.

CEITEC Masaryk University Brno Czechia

Center of Oncocytogenetics Institute of Clinical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University and General University Hospital Prague Czechia

Department of Clinical Immunology and Allergology St Anne's University Hospital Brno Brno Czechia

Department of Medical Genetics University Hospital Brno Brno Czechia

Department of Paediatric Haematology and Oncology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czechia

Department of Paediatrics 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czechia

Department of Paediatrics University Hospital Brno Brno Czechia

Department of Pediatric Hematology University Hospital Brno Brno Czechia

Faculty of Medicine Masaryk University Brno Czechia

Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czechia

Molecular Genetics Laboratory Center of Cardiovascular Surgery and Transplantation Brno Czechia

Zobrazit více v PubMed

Narumi S, Amano N, Ishii T, Katsumata N, Muroya K, Adachi M, et al. . SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome and are associated with loss of chromosome 7. Nat Genet. (2016) 48:792–7. 10.1038/ng.3569 PubMed DOI

Buonocore F, Kühnen P, Suntharalingham JP, Del Valle I, Digweed M, Stachelscheid H, et al. . Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest. (2017) 127:1700–13. 10.1172/JCI91913 PubMed DOI PMC

Schwartz JR, Wang S, Ma J, Lamprecht T, Walsh M, Song G, et al. . Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome. Leukemia. (2017) 31:1827–30. 10.1038/leu.2017.142 PubMed DOI PMC

Chen DH, Below JE, Shimamura A, Keel SB, Matsushita M, Wolff J, et al. . Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L. Am J Hum Genet. (2016) 98:1146–58. 10.1016/j.ajhg.2016.04.009 PubMed DOI PMC

Bluteau O, Sebert M, Leblanc T, Peffault de Latour R, Quentin S, Lainey E, et al. . A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. Blood. (2018) 131:717–32. 10.1182/blood-2017-09-806489 PubMed DOI

Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. (2009) 4:1073–81. 10.1038/nprot.2009.86 PubMed DOI

Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. (2013) Chapter 7:Unit7.20. 10.1002/0471142905.hg0720s76 PubMed DOI PMC

Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. (2014) 46:310–5. 10.1038/ng.2892 PubMed DOI PMC

Sarthy J, Zha J, Babushok D, Shenoy A, Fan JM, Wertheim G, et al. . Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype. (2018) 2:3–8. 10.1182/bloodadvances.2017012682 PubMed DOI PMC

Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. . Analysis of protein-coding genetic variation in 60,706 humans. Nature. (2016) 536:285–91. 10.1038/nature19057 PubMed DOI PMC

Flanagan SE, Patch AM, Ellard S. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomark. (2010) 14:533–7. 10.1089/gtmb.2010.0036 PubMed DOI

Wilson DB, Bessler M, Ferkol TW, Shenoy S, Amano N, Ishii T, et al. . Comment on: acquired monosomy 7 myelodysplastic syndrome in a child with clinical features of dyskeratosis congenita and IMAGe association. Pediatr. Blood Cancer. (2018) 65:e26747. 10.1002/pbc.26747 PubMed DOI

Mekhedov SL, Makarova KS, Koonin EV. The complex domain architecture of SAMD9 family proteins, predicted STAND-like NTPases, suggests new links to inflammation and apoptosis. Biol Direct. (2017) 12:13. 10.1186/s13062-017-0185-2 PubMed DOI PMC

Wong JC, Bryant V, Lamprecht T, Ma J, Walsh M, Schwartz J, et al. . Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. JCI Insight. (2018) 3:121086. 10.1172/jci.insight.121086 PubMed DOI PMC

Pelák O, Stuchlý J, Król L, Hubáček P, Keslová P, Sedláček P, et al. . Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation. Cytom. Part B Clin. Cytom. (2017) 92:380–8. 10.1002/cyto.b.21348 PubMed DOI

Horejsí V, Angelisová P, Bazil V, Kristofová H, Stoyanov S, Stefanová I, et al. . Monoclonal antibodies against human leucocyte antigens. II. Antibodies against CD45 (T200), CD3 (T3), CD43, CD10 (CALLA), transferrin receptor (T9), a novel broadly expressed 18-kDa antigen (MEM-43) and a novel antigen of restricted expression (MEM-74). Folia Biol. (1988) 34:23–34. PubMed

Knapp W. Leucocyte Typing IV : White Cell Differentiation Antigens. New York, NY: Oxford University Press; (1989).

Fronková E, Klocperk A, Svaton M, Nováková M, Kotrová M, Kayserová J, et al. . The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome. PLoS ONE. (2014) 9:e114514. 10.1371/journal.pone.0114514 PubMed DOI PMC

Sottini A, Ghidini C, Zanotti C, Chiarini M, Caimi L, Lanfranchi A, et al. . Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation. Clin Immunol. (2010) 136:217–27. 10.1016/j.clim.2010.04.005 PubMed DOI